Skip to main content
letter
. 2020 Jun 9;35(8):2516–2517. doi: 10.1007/s11606-020-05937-5

Table 1.

Univariate and multivariate analyses of demographic, comorbidity and clinical indices among hospitalized and outpatient cohorts

Mortality
Univariate Analysis OR (95% CI) Pvalue
Demographics
Age > 60 years 3.4 (2.8,4.1) <0.0005
Male 1.4 (1.2,1.7) <0.0005
Caucasian Race compared to African-American 1.4 (1.0,2.0) 0.037
Other Race compared to African-American 0.87 (0.61,1.3) 0.467
Smoking history 1.4 (0.83, 2.3) 0.212
BMI > 30 1.5 (1.2,1.9) 0.002
Medications
NSAID use 1.0 (0.85,1.2) 0.831
ACE-I/ARB use 2.4 (2.0,2.9) <0.0005
Comorbidities
CCI > 2 5.2 (4.2,6.5) <0.0005
HTN 4.4 (3.6,5.4) <0.0005
DM 3.9 (3.0,5.1) <0.0005
CKD 8.0 (5.0,12.9) <0.0005
COPD 2.5 (1.6,4.0) <0.0005
CAD/PAD 4.2 (2.8, 6.1) <0.0005
Cancer 2.4 (1.5,4.0) <0.0005
Heart Failure 4.4 (2.3,8.6) <0.0005
OSA 2.2 (1.5,3.3) <0.0005
Bronchial Asthma 1.4 (1.0,2.0) 0.053
CVA or TIA 14.3 (5.3, 39.2) <0.0005
VTE 3.0 (1.7,5.5) <0.0005
Dementia 2.5 (0.70,8.6) 0.162
Immunosuppression 1.2 (0.46,3.2) 0.685
Peptic Ulcer Disease 5.4 (1.3,23.3) 0.023
Connective Tissue Disease 1.9 (0.95,4.00) 0.068
Vitals Signs
Tachycardia (HR > 100 beats/min) 1.6 (1.3,1.9) <0.0005
Tachypnea (RR > 20 breaths/min) 5.3 (4.0,7.1) <0.0005
Hypoxia (SpO2 < 90%) 21.7 (8.0,59.1) <0.0005
Multivariate Analysis
Variable aOR (95% CI) Pvalue
Age > 60 2.1 (1.4,3.1) 0.015
CCI > 21 3.2 (2.1,4.8) <0.0005
Male 1.9 (1.5,2.5) <0.0005
Caucasian Race compared to African-American 1.4 (0.83,2.3) 0.220
ACE-I/ARB use 1.5 (1.1,2.0) 0.015
Other race compared to African-American 0.90 (0.53,1.6) 0.709
BMI > 30 1.8 (1.4,2.4) <0.0005
Tachycardia (HR > 100 bpm) 1.5 (1.1,2.0) 0.007
Tachypnea (RR > 20 breaths/min) 2.9 (2.1,4.1) <0.0005
Hypoxia (SpO2 < 90%) 15.0 (4.7,48.0) <0.0005

Abbreviations: CKD, chronic kidney disease; COPD: chronic obstructive pulmonary disease; OSA: Obstructive Sleep Apnea; HTN, hypertension; VTE, venous thromboembolic disease; TIA, Transient Ischemic Attack; CVA, Cerebrovascular Accident; NSAIDs: Non-steroidal anti-inflammatory medication; ACE-I: angiotensin converting enzyme-inhibitor; ARB: angiotensin receptor blocker; OR: Odds ratio; aOR: adjusted odds ratio; CI, confidence interval; CAD, coronary artery disease; PAD, peripheral artery disease; CCI, Charlson Comorbidity Index; RR: respiratory rate; HR, heart rate; SpO2, oxygen saturation; BMI, body mass index; bpm, beats per minute

CCI utilized in multivariate analysis as surrogate for comorbidities